ZHIMENG BIOPHARMA

zhimeng-biopharma-logo

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.

#SimilarOrganizations #People #Financial #Website #More

ZHIMENG BIOPHARMA

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2017-01-01

Address:
Pudong, Shandong, China

Country:
China

Website Url:
http://www.core-biopharma.com

Total Employee:
11+

Status:
Active

Contact:
+86 21-50391670

Total Funding:
196.75 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx Euro JsDelivr PHP Pound Sterling


Similar Organizations

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

ksq-therapeutics-logo

KSQ Therapeutics

KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

Current Employees Featured

huanming-chen_image

Huanming Chen
Huanming Chen Co-founder, President, and Chief Executive Officer @ Zhimeng Biopharma
Co-founder, President, and Chief Executive Officer

zhijun-zhang_image

Zhijun Zhang
Zhijun Zhang Co-founder, Vice President and CSO @ Zhimeng Biopharma
Co-founder, Vice President and CSO

Founder


huanming-chen_image

Huanming Chen

zhijun-zhang_image

Zhijun Zhang

Investors List

advantech-capital_image

Advantech Capital

Advantech Capital investment in Series B - Zhimeng Biopharma

co-stone-capital_image

Co-Stone Venture Capital

Co-Stone Venture Capital investment in Series B - Zhimeng Biopharma

fortune-venture-capital_image

Fortune Venture Capital

Fortune Venture Capital investment in Series B - Zhimeng Biopharma

dawu-venture-capital_image

Dawu Venture Capital

Dawu Venture Capital investment in Series B - Zhimeng Biopharma

dyee-capital_image

Dyee Capital

Dyee Capital investment in Series B - Zhimeng Biopharma

shenzhen-capital-group_image

Shenzhen Capital Group

Shenzhen Capital Group investment in Venture Round - Zhimeng Biopharma

Official Site Inspections

http://www.core-biopharma.com Semrush global rank: 7.26 M Semrush visits lastest month: 548

  • Host name: 47.92.230.99
  • IP address: 47.92.230.99
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "Zhimeng Biopharma" on Search Engine